Literature DB >> 863985

Mass fragmentographic assay of nanogram amounts of the antidepressant drug mianserin hydrochloride (Org GB 94) in human plasma.

J J de Ridder, P C Koppens, H J van Hal.   

Abstract

For the assay of the antidepressant compound mianserin hydrochloride (Org GB 94) in human plasma, a mass fragmentographic method, using the deuterated analogue as internal standard and a high-performance liquid chromatographie sample clean-up procedure has been developed. The assay specifications obtained are a lower limit for reliable measurements of 1 ng/ml, and accuracy of ca. 0.01 ng/ml, a precision of 6--7% and a capacity of about 60 samples per day. The applicability of the assay method is illustrated by measurements of single-dose and steady-state plasma levels in clinical experiments, demonstrating the possibility of monitoring plasma levels during at least 24 h after a single dose of 15 mg of Org GB 94. The mean steady-state plasma levels after a daily dose of 3 X 20 mg of Org GB 94 appeared to be remarkably constant with time: 38, 36 and 34 ng/ml after 2, 4, and 6 weeks of treatment of 18 depressed patients.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 863985     DOI: 10.1016/s0378-4347(00)81809-5

Source DB:  PubMed          Journal:  J Chromatogr


  6 in total

1.  Electroencephalogram study of mianserin in depressed patients.

Authors:  P Irwin; M Fink
Journal:  Br J Clin Pharmacol       Date:  1978       Impact factor: 4.335

2.  Influence of age on mianserin pharmacokinetics.

Authors:  A C Altamura; T Melorio; G Invernizzi; R Gomeni
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

3.  A pharmacokinetic study of mianserin.

Authors:  K P Maguire; T R Norman; G D Burrows; B A Scoggins
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  A simplified method for the estimation of mianserin in plasma.

Authors:  J Lewis; K D Cairncross
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

Review 5.  Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

6.  Pharmacodynamic studies on mianserin and its interaction with clonidine.

Authors:  H L Elliott; K McLean; D J Sumner; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.